A study to evaluate the long term effect of sirolimus treatment on serum levels of VEGF-D in patients with lymphangioleiomyomatosis.
Phase of Trial: Phase IV
Latest Information Update: 19 Aug 2015
At a glance
- Drugs Sirolimus (Primary)
- Indications Lymphangioleiomyomatosis
- Focus Therapeutic Use
- 19 Aug 2015 New trial record